These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19591966)

  • 21. Genetic disorders of the LRP5-Wnt signalling pathway affecting the skeleton.
    Koay MA; Brown MA
    Trends Mol Med; 2005 Mar; 11(3):129-37. PubMed ID: 15760771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesd is a universal inhibitor of Wnt coreceptors LRP5 and LRP6 and blocks Wnt/beta-catenin signaling in cancer cells.
    Lu W; Liu CC; Thottassery JV; Bu G; Li Y
    Biochemistry; 2010 Jun; 49(22):4635-43. PubMed ID: 20446724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LRP4 association to bone properties and fracture and interaction with genes in the Wnt- and BMP signaling pathways.
    Kumar J; Swanberg M; McGuigan F; Callreus M; Gerdhem P; Akesson K
    Bone; 2011 Sep; 49(3):343-8. PubMed ID: 21645651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New explanation for autosomal dominant high bone mass: Mutation of low-density lipoprotein receptor-related protein 6.
    Whyte MP; McAlister WH; Zhang F; Bijanki VN; Nenninger A; Gottesman GS; Lin EL; Huskey M; Duan S; Dahir K; Mumm S
    Bone; 2019 Oct; 127():228-243. PubMed ID: 31085352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neural regulation of bone and the skeletal effects of serotonin (5-hydroxytryptamine).
    Warden SJ; Bliziotes MM; Wiren KM; Eshleman AJ; Turner CH
    Mol Cell Endocrinol; 2005 Oct; 242(1-2):1-9. PubMed ID: 16085354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop.
    Rawadi G; Vayssière B; Dunn F; Baron R; Roman-Roman S
    J Bone Miner Res; 2003 Oct; 18(10):1842-53. PubMed ID: 14584895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parameters of LRP5 from a structural and molecular perspective.
    Johnson ML; Summerfield DT
    Crit Rev Eukaryot Gene Expr; 2005; 15(3):229-42. PubMed ID: 16390319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechano-transduction in osteoblastic cells involves strain-regulated estrogen receptor alpha-mediated control of insulin-like growth factor (IGF) I receptor sensitivity to Ambient IGF, leading to phosphatidylinositol 3-kinase/AKT-dependent Wnt/LRP5 receptor-independent activation of beta-catenin signaling.
    Sunters A; Armstrong VJ; Zaman G; Kypta RM; Kawano Y; Lanyon LE; Price JS
    J Biol Chem; 2010 Mar; 285(12):8743-58. PubMed ID: 20042609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-deletion of Lrp5 and Lrp6 in the skeleton severely diminishes bone gain from sclerostin antibody administration.
    Lim KE; Bullock WA; Horan DJ; Williams BO; Warman ML; Robling AG
    Bone; 2021 Feb; 143():115708. PubMed ID: 33164872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity.
    Ellies DL; Viviano B; McCarthy J; Rey JP; Itasaki N; Saunders S; Krumlauf R
    J Bone Miner Res; 2006 Nov; 21(11):1738-49. PubMed ID: 17002572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A cell-based Dkk1 binding assay reveals roles for extracellular domains of LRP5 in Dkk1 interaction and highlights differences between wild-type and the high bone mass mutant LRP5(G171V).
    Murrills RJ; Matteo JJ; Bhat BM; Coleburn VE; Allen KM; Chen W; Damagnez V; Bhat RA; Bex FJ; Bodine PV
    J Cell Biochem; 2009 Dec; 108(5):1066-75. PubMed ID: 19746449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from clinical studies.
    Haney EM; Warden SJ
    J Musculoskelet Neuronal Interact; 2008; 8(2):133-45. PubMed ID: 18622082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oropharyngeal skeletal disease accompanying high bone mass and novel LRP5 mutation.
    Rickels MR; Zhang X; Mumm S; Whyte MP
    J Bone Miner Res; 2005 May; 20(5):878-85. PubMed ID: 15824861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of the Wnt/LRP5/β-catenin signaling pathway on the pathogenesis of postmenopausal osteoporosis].
    Wang Y; Liu Y; Ma JX; Li BX; Li YK
    Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):769-72. PubMed ID: 22321352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-375-3p negatively regulates osteogenesis by targeting and decreasing the expression levels of LRP5 and β-catenin.
    Sun T; Li CT; Xiong L; Ning Z; Leung F; Peng S; Lu WW
    PLoS One; 2017; 12(2):e0171281. PubMed ID: 28158288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lrp5 and Lrp6 exert overlapping functions in osteoblasts during postnatal bone acquisition.
    Riddle RC; Diegel CR; Leslie JM; Van Koevering KK; Faugere MC; Clemens TL; Williams BO
    PLoS One; 2013; 8(5):e63323. PubMed ID: 23675479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Wnt-beta-catenin signaling in bone metabolism].
    Urano T
    Clin Calcium; 2006 Jan; 16(1):54-60. PubMed ID: 16397351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High bone mass in mice expressing a mutant LRP5 gene.
    Babij P; Zhao W; Small C; Kharode Y; Yaworsky PJ; Bouxsein ML; Reddy PS; Bodine PV; Robinson JA; Bhat B; Marzolf J; Moran RA; Bex F
    J Bone Miner Res; 2003 Jun; 18(6):960-74. PubMed ID: 12817748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring the mechanism of traditional Chinese medicine in regulating gut-derived 5-HT for osteoporosis treatment.
    Sun K; Wang Y; Du J; Wang Y; Liu B; Li X; Zhang X; Xu X
    Front Endocrinol (Lausanne); 2023; 14():1234683. PubMed ID: 37916145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.
    Gong Y; Slee RB; Fukai N; Rawadi G; Roman-Roman S; Reginato AM; Wang H; Cundy T; Glorieux FH; Lev D; Zacharin M; Oexle K; Marcelino J; Suwairi W; Heeger S; Sabatakos G; Apte S; Adkins WN; Allgrove J; Arslan-Kirchner M; Batch JA; Beighton P; Black GC; Boles RG; Boon LM; Borrone C; Brunner HG; Carle GF; Dallapiccola B; De Paepe A; Floege B; Halfhide ML; Hall B; Hennekam RC; Hirose T; Jans A; Jüppner H; Kim CA; Keppler-Noreuil K; Kohlschuetter A; LaCombe D; Lambert M; Lemyre E; Letteboer T; Peltonen L; Ramesar RS; Romanengo M; Somer H; Steichen-Gersdorf E; Steinmann B; Sullivan B; Superti-Furga A; Swoboda W; van den Boogaard MJ; Van Hul W; Vikkula M; Votruba M; Zabel B; Garcia T; Baron R; Olsen BR; Warman ML;
    Cell; 2001 Nov; 107(4):513-23. PubMed ID: 11719191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.